144 related articles for article (PubMed ID: 20549082)
1. Expression of genes that encode the annexin-1 and galectin-1 proteins in nasal polyposis and their modulation by glucocorticoid.
Fernandes AM; Babeto E; Rahal P; Provazzi PJ; Hidalgo CA; Anselmo-Lima WT
Braz J Otorhinolaryngol; 2010; 76(2):213-8. PubMed ID: 20549082
[TBL] [Abstract][Full Text] [Related]
2. Spatial expression of two anti-inflammatory mediators, annexin 1 and galectin-1, in nasal polyposis.
Sena AA; Provazzi PJ; Fernandes AM; Cury PM; Rahal P; Oliani SM
Clin Exp Allergy; 2006 Oct; 36(10):1260-7. PubMed ID: 17014434
[TBL] [Abstract][Full Text] [Related]
3. Gene profiling reveals increased expression of uteroglobin and other anti-inflammatory genes in glucocorticoid-treated nasal polyps.
Benson M; Carlsson L; Adner M; Jernås M; Rudemo M; Sjögren A; Svensson PA; Uddman R; Cardell LO
J Allergy Clin Immunol; 2004 Jun; 113(6):1137-43. PubMed ID: 15208596
[TBL] [Abstract][Full Text] [Related]
4. Expression patterns of galectin-1 and galectin-3 in nasal polyps and middle and inferior turbinates in relation to growth regulation and immunosuppression.
Delbrouck C; Gabius HJ; Kaltner H; Decaestecker C; Kiss R; Hassid S
Arch Otolaryngol Head Neck Surg; 2003 Jun; 129(6):665-9. PubMed ID: 12810474
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of glucocorticoids in nasal polyposis.
Fernandes AM; Valera FC; Anselmo-Lima WT
Braz J Otorhinolaryngol; 2008; 74(2):279-83. PubMed ID: 18568209
[TBL] [Abstract][Full Text] [Related]
6. Expression profiles of CD11b, galectin-1, beclin-1, and caspase-3 in nasal polyposis.
Dilci A; Varol N; Kılıçcıoğlu İ; Konac E; Aydil U; Kızıl Y; Uslu S
Turk J Med Sci; 2017 Dec; 47(6):1757-1764. PubMed ID: 29306235
[TBL] [Abstract][Full Text] [Related]
7. Expression of annexin-A1 and galectin-1 anti-inflammatory proteins and mRNA in chronic gastritis and gastric cancer.
Jorge YC; Mataruco MM; Araújo LP; Rossi AF; de Oliveira JG; Valsechi MC; Caetano A; Miyazaki K; Fazzio CS; Thomé JA; Rahal P; Oliani SM; Silva AE
Mediators Inflamm; 2013; 2013():152860. PubMed ID: 23431236
[TBL] [Abstract][Full Text] [Related]
8. Nasal polyps treatment: medical management.
Mygind N; Lildholdt T
Allergy Asthma Proc; 1996; 17(5):275-82. PubMed ID: 8922147
[TBL] [Abstract][Full Text] [Related]
9. Treatment outcomes and predictors for systemic steroids in nasal polyposis.
Won TB; Jang E; Min SK; Kim SW
Acta Otolaryngol; 2012 Jun; 132 Suppl 1():S82-7. PubMed ID: 22582788
[TBL] [Abstract][Full Text] [Related]
10. Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis.
Beer H; Southern KW; Swift AC
Cochrane Database Syst Rev; 2013 Apr; (4):CD008253. PubMed ID: 23633352
[TBL] [Abstract][Full Text] [Related]
11. Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis.
Beer H; Southern KW; Swift AC
Cochrane Database Syst Rev; 2011 May; (5):CD008253. PubMed ID: 21563167
[TBL] [Abstract][Full Text] [Related]
12. Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis.
Beer H; Southern KW; Swift AC
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD008253. PubMed ID: 26098667
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of steroid treatment in nasal polyposis.
Tuncer U; Soylu L; Aydogan B; Karakus F; Akcali C
Auris Nasus Larynx; 2003 Aug; 30(3):263-8. PubMed ID: 12927289
[TBL] [Abstract][Full Text] [Related]
14. Regulation of expression of galectin-7 in human nasal polyps by budesonide.
Delbrouck C; Souchay C; Kaltner H; André S; Gabius HJ; Vandenhoven G; Hassid S
B-ENT; 2005; 1(3):137-44. PubMed ID: 16255498
[TBL] [Abstract][Full Text] [Related]
15. Galectin-1 is overexpressed in nasal polyps under budesonide and inhibits eosinophil migration.
Delbrouck C; Doyen I; Belot N; Decaestecker C; Ghanooni R; de Lavareille A; Kaltner H; Choufani G; Danguy A; Vandenhoven G; Gabius HJ; Hassid S; Kiss R
Lab Invest; 2002 Feb; 82(2):147-58. PubMed ID: 11850528
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid treatment for nasal polyps. The use of topical budesonide powder, intramuscular betamethasone, and surgical treatment.
Lildholdt T; Rundcrantz H; Bende M; Larsen K
Arch Otolaryngol Head Neck Surg; 1997 Jun; 123(6):595-600. PubMed ID: 9193219
[TBL] [Abstract][Full Text] [Related]
17. Changes of glucocorticoid receptor expression in the nasal polyps of patients with chronic sinusitis following treatment with glucocorticoid.
Watanabe S; Suzaki H
In Vivo; 2008; 22(1):37-42. PubMed ID: 18396779
[TBL] [Abstract][Full Text] [Related]
18. Surgical versus medical treatment of nasal polyps.
Lildholdt T; Fogstrup J; Gammelgaard N; Kortholm B; Ulsoe C
Acta Otolaryngol; 1988; 105(1-2):140-3. PubMed ID: 3341154
[TBL] [Abstract][Full Text] [Related]
19. Expression of intercellular adhesion molecule-1 on the vascular endothelium in nasal polyps before, during and after topical glucocorticoid treatment.
Tingsgaard PK; Larsen PL; Bock T; Lange Vejlsgaard G; Tos M
Acta Otolaryngol; 1998 Jun; 118(3):404-8. PubMed ID: 9655217
[TBL] [Abstract][Full Text] [Related]
20. Unexpected effects of systemic steroids on the CRSwNP proteome: is protein upregulation more important than inhibition?
Workman AD; Miyake MM; Nocera AL; Mueller SK; Finn K; Otu HH; Libermann TA; Bleier BS
Int Forum Allergy Rhinol; 2020 Mar; 10(3):334-342. PubMed ID: 32022468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
